Overview

A Phase 4 Study Investigating the Efficacy of Retaine™ in Managing Signs and Symptoms Associated With Dry Eye Syndrome

Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy of Retaine™ ophthalmic emulsion in treating the signs and symptoms of dry eye syndrome.
Phase:
Phase 4
Details
Lead Sponsor:
Ocusoft, Inc.
Collaborator:
ORA, Inc.
Treatments:
Carboxymethylcellulose Sodium